Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • City council reviews...

    City council reviews use of Bayer Roundup weed killer amid cancer fears

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-07-08T09:15:06+05:30  |  Updated On 8 July 2019 9:15 AM IST
    City council reviews use of Bayer Roundup weed killer amid cancer fears

    Bayer says Roundup is safe and backed by several regulatory bodies, despite research that found its main ingredient glyphosate was probably carcinogenic.


    SYDNEY: Sydney's city council said on Friday it was reviewing its weed management, which included the use of Bayer AG's Roundup, after other councils in Australia began cutting ties with the product amid concerns about possible links to cancer.


    The council, which covers the city's business centre, was "reviewing (its) weed management methods and investigating other technologies", a spokeswoman told Reuters in an email, a day after a strike by workers at a nearby council pressured it into a trialing an alternative weedkiller.


    The City of Sydney council currently used Roundup "as a last resort ... when non-pesticide methods such as hand-weeding and mulching have been ineffective", and began testing alternative products in late 2018, the spokeswoman added.


    Bayer says Roundup is safe and backed by several regulatory bodies, despite research that found its main ingredient glyphosate was probably carcinogenic.


    The German company has been hit by massive compensation payouts in the United States this year, over claims its product caused cancer, which has seen its share price to plummet.


    The prospect of Sydney council rethinking its ties to Roundup, a flagship product of U.S. agribusiness giant Monsanto Co until a buyout from Bayer last year, shows the pressure that grassroots campaigns and lawsuits are putting on governments about the product even as regulators declare it safe.


    "Because there's a lot of emotion around it, local agencies may be moved to make a decision that's made based on placating the general public rather than the available science," said Ian Musgrave, a molecular pharmacologist and toxicologist at the University of Adelaide.


    "We should be making decisions on safety based on actual science, not based on our fear or dismay of megacorporations."


    Earlier this week, Blacktown City Council in Sydney's west agreed to trial an alternative to Roundup after a worker strike over the product left 40,000 garbage bins not emptied.


    Another four councils around Sydney previously quit using Roundup over possible links to cancer.


    Last month, an Australian gardener filed the country's first lawsuit against Bayer, accusing Monsanto of causing him to harm from exposure to glyphosate via decades of using Roundup.


    A Bayer spokesman said the company "encourages constructive dialogue with our stakeholders to build a broader trust in science".


    The company had published "extensive research which supports our products' safety" and was "committed to ensuring our customers continue to have access to these critical products as part of their sustainable agricultural activities".


    Also Read: Bayer contested Glyphosate use will eventually end, says German Chancellor

    Bayerbayer roundupcancercarcinogenicglyphosatelawsuitMonsantopharmapharma newspharma news indiaweed
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok